Stock Earnings

Question 1

Mersana Therapeutics Incの主要な財務諸表は何ですか？

Accepted Answer

最新の財務諸表（Form-10K）によると、Mersana Therapeutics Incの総資産は$144で、純lossは$-69です。

Question 2

MRSNの主要な財務比率は何ですか？

Accepted Answer

Mersana Therapeutics Incの流動比率は0.93、純利益率は-172.5、1株当たり売上高は$8.16です。

Question 3

Mersana Therapeutics Incの収益はセグメントまたは地域別にどのように分けられていますか？

Accepted Answer

Mersana Therapeutics Inc largest revenue segment is Antibody-drug Conjugates, at a revenue of 40,497,000 in the most earnings release.For geography, United States is the primary market for Mersana Therapeutics Inc, at a revenue of 40,497,000.

Question 4

Mersana Therapeutics Incは収益を上げていますか？

Accepted Answer

no、最新の財務諸表によると、Mersana Therapeutics Incの純lossは$-69です。

Question 5

Mersana Therapeutics Incに負債はありますか？

Accepted Answer

yes、Mersana Therapeutics Incの負債は154です。

Question 6

Mersana Therapeutics Incの発行済株式数は何株ですか？

Accepted Answer

Mersana Therapeutics Incの総発行済株式数は4.62株です。

Breakdown	TTM	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020
Revenue	34	40	36	26	0	0
Revenue Growth (YoY)	17%	11%	38%	--	--	-100%
Cost of Revenue	--	--	--	--	--	--
Gross Profit	--	--	--	--	--	--
Selling, General & Admin	35	40	59	56	36	21
Research & Development	71	73	148	173	132	67
Operating Expenses	106	113	207	230	168	88
Other Non Operating Income (Expenses)	--	--	--	--	--	--
Pretax Income	-73	-68	-171	-204	-170	-88
Income Tax Expense	--	0	--	--	--	--
Net Income	-74	-69	-171	-204	-170	-88
Net Income Growth	-28.99%	-60%	-16%	20%	93%	214%
Shares Outstanding (Diluted)	4.98	4.9	4.64	3.74	2.82	2.45
Shares Change (YoY)	2%	6%	24%	33%	15%	41%
EPS (Diluted)	-14.84	-14.11	-36.96	-54.51	-60.23	-35.8
EPS Growth	-31%	-62%	-32%	-10%	68%	121%
Free Cash Flow	-79	-82	-171	-51	-140	-75
Free Cash Flow Per Share	-15.84	-16.72	-36.81	-13.61	-49.58	-30.49
Gross Margin	--	--	--	--	--	--
Operating Margin	-208.82%	-182.5%	-472.22%	-780.76%	0%	0%
Profit Margin	-217.64%	-172.5%	-475%	-784.61%	0%	0%
Free Cash Flow Margin	-232.35%	-204.99%	-475%	-196.15%	0%	0%
EBITDA	-70	-72	-169	-203	-168	-87
EBITDA Margin	-205.88%	-180%	-469.44%	-780.76%	0%	0%
D&A For EBITDA	1	1	1	0	0	1
EBIT	-71	-73	-170	-203	-168	-88
EBIT Margin	-208.82%	-182.5%	-472.22%	-780.76%	0%	0%
Effective Tax Rate	--	0%	--	--	--	--

Mersana Therapeutics Inc (MRSN) Price

MRSN Stock Price Chart

MRSN Income

Follow-Up Questions